![[SIGN thistle header]](../../../images/page-header-template.jpg)
The recommendations with resource implications are discussed in Annex 3.
11.1 Managed clinical networks
Managed Clinical Networks (MCNs) are defined as: ‘linked groups of health professionals and organisations from primary, secondary and tertiary care, working in a coordinated manner, unconstrained by existing professional and Health Board boundaries, to ensure equitable provision of high quality clinically effective services throughout Scotland.’ 178
MCNs require an administrative infrastructure so they have financial implications. In the case of ovarian cancer, the core members of the MCN would be allied health professionals, gynaecological oncologists, general practitioners, laboratory medicine specialists, gynaecologists, medical and clinical oncologists, nurses, pathologists, radiologists and palliative care specialists.
| The health professionals involved in the care of women with ovarian cancer should be represented in a managed clinical network. |
11.2 Recommendations for research
Surgical and chemotherapy research questions need to be answered by large randomised controlled trials. Patients should be entered into appropriate clinical trials wherever possible (eg MRC, EORTC, GOG and the Scottish Gynaecological Cancer Trials Group). Seven other areas where evidence is lacking have been identified in the course of developing this guideline: